Sign up
Log in
News
ORMP
2.600
+2.36%
0.060
Weekly Report: what happened at ORMP last week (0715-0719)?
Weekly Report · 4d ago
Weekly Report: what happened at ORMP last week (0708-0712)?
Weekly Report · 07/15 10:20
Weekly Report: what happened at ORMP last week (0701-0705)?
Weekly Report · 07/08 10:20
Weekly Report: what happened at ORMP last week (0624-0628)?
Weekly Report · 07/01 10:21
Oramed Pharmaceuticals authorizes share buyback program
Seeking Alpha · 06/26 13:15
ORAMED PHARMACEUTICALS: HTIT COMMITTING $70 MLN IN CASH, CO INVESTING $25 MLN IN CASH & STOCK IN JV
Reuters · 06/26 13:12
ORAMED PHARMACEUTICALS - AUTHORIZED COMMON STOCK REPURCHASE PLAN ALLOWING FOR BUY-BACK OF UP TO $20 MLN IN MAXIMUM VALUE OF ITS COMMON STOCK
Reuters · 06/26 13:00
ORAMED PHARMACEUTICALS INC. ANNOUNCES THE BUY-BACK OF ITS COMMON STOCK
Reuters · 06/26 13:00
Weekly Report: what happened at ORMP last week (0617-0621)?
Weekly Report · 06/24 10:25
Weekly Report: what happened at ORMP last week (0610-0614)?
Weekly Report · 06/17 10:20
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Avidity Biosciences (NASDAQ:RNA) shares rose 24.5% to $36.0 during Wednesday's pre-market session. Molecular Partners shares moved upwards by 18.43% during the day. The company's market cap stands at $3.4 billion.
Benzinga · 06/12 12:06
Oramed Pharm Names Avraham Gabay as New CFO
TipRanks · 06/10 21:54
ORAMED PHARMACEUTICALS INC - ON JUNE 6, APPOINTED AVRAHAM GABAY TO SERVE AS CFO, TREASURER AND SECRETARY
Reuters · 06/10 21:30
Weekly Report: what happened at ORMP last week (0603-0607)?
Weekly Report · 06/10 10:21
Weekly Report: what happened at ORMP last week (0527-0531)?
Weekly Report · 06/03 10:23
Weekly Report: what happened at ORMP last week (0520-0524)?
Weekly Report · 05/27 10:26
HC Wainwright & Co. Reiterates Neutral on Oramed Pharmaceuticals
Benzinga · 05/20 11:21
H.C. Wainwright Sticks to Their Hold Rating for Oramed Pharm (ORMP)
TipRanks · 05/20 10:36
Weekly Report: what happened at ORMP last week (0513-0517)?
Weekly Report · 05/20 10:22
Compugen Appoints David Silberman As Its New CFO Effective August 15, 2024, Taking Over From Alberto Sessa Who Will Depart On The Same Day
Benzinga · 05/15 11:13
More
Webull provides a variety of real-time ORMP stock news. You can receive the latest news about Oramed Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About ORMP
Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1). Its oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes through oral delivery of insulin at an earlier stage of treatment. Its oral insulin capsule (ORMD-0801) has shown a reduction of liver fat content in early clinical trials. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone that stimulates the secretion of insulin from the pancreas.